Professor Ben Tsang joined the University of Ottawa (uOttawa) in 1980 as the Director, Reproductive Biology Unit and subsequently served as the Associate Chair (Research) of the Department of Obstetrics and Gynecology and the Director of Research of the Ottawa Civic Hospital. He is currently Full Professor of Obstetrics & Gynaecology and Cellular & Molecular Medicine and Senior Scientist in the Chronic Disease Program, Ottawa Hospital Research Institute (OHRI).
Professor Tsang is internationally recognized for his translational research program in cell fate regulation in women’s reproductive health, especially in the area of anovulatory infertility and chemoresistant ovarian cancer. His research program has been supported continuously by national competitive grants from MRC/CIHR during the past 37 years. He has contributed over 215 full-length original publications and 21 reviews/book chapters, and holds 4 patents. The success of Dr. Tsang’s research is reflected in the numerous honours and awards he received, including the CFAS Award of Excellence in Reproductive Medicine, the Ottawa Centre for Research and Innovations Research Award, the Ottawa Regional Cancer Foundation Angel Award for cancer research excellence, the J David Grimes Research Career Achievement Award, and the uOttawa Faculty of Medicine Award of Excellence. He was appointed the World Class University Professor of Biomodulation at Seoul National University.
Dr. Tsang is the Co-editor-in-Chief of the Journal of Ovarian Research and Associate Editor of Molecular Carcinogenesis and Journal of Cancer Prevention. He has served on the Editorial Board of Endocrinology, Biology of Reproduction, Reproduction, Clinical and Experimental Reproductive Medicine and Adaptive Medicine, and on various CIHR grant committees. He holds honorary professorships at the Chinese Academy of Sciences, Jinan University, Nanjing Medical University and Taipei Medical University.
Professor Tsang served as co-chairs of the China-Canada Bilateral Program on Reproductive Health and the Canada-Japan Bilateral Program on Women’s Health Research in the promotion of international research partnerships and academic exchanges. He served as President of the Canadian Fertility and Andrology Society and a member of the Board of Directors of the Society for the Study of Reproduction (SSR). He is the Chair of the SSR Golden Anniversary Fundraising Campaign.
Professor Tsang is internationally recognized for his translational research program in cell fate regulation in women’s reproductive health, especially in the area of anovulatory infertility and chemoresistant ovarian cancer. His research program has been supported continuously by national competitive grants from MRC/CIHR during the past 37 years. He has contributed over 215 full-length original publications and 21 reviews/book chapters, and holds 4 patents. The success of Dr. Tsang’s research is reflected in the numerous honours and awards he received, including the CFAS Award of Excellence in Reproductive Medicine, the Ottawa Centre for Research and Innovations Research Award, the Ottawa Regional Cancer Foundation Angel Award for cancer research excellence, the J David Grimes Research Career Achievement Award, and the uOttawa Faculty of Medicine Award of Excellence. He was appointed the World Class University Professor of Biomodulation at Seoul National University.
Dr. Tsang is the Co-editor-in-Chief of the Journal of Ovarian Research and Associate Editor of Molecular Carcinogenesis and Journal of Cancer Prevention. He has served on the Editorial Board of Endocrinology, Biology of Reproduction, Reproduction, Clinical and Experimental Reproductive Medicine and Adaptive Medicine, and on various CIHR grant committees. He holds honorary professorships at the Chinese Academy of Sciences, Jinan University, Nanjing Medical University and Taipei Medical University.
Professor Tsang served as co-chairs of the China-Canada Bilateral Program on Reproductive Health and the Canada-Japan Bilateral Program on Women’s Health Research in the promotion of international research partnerships and academic exchanges. He served as President of the Canadian Fertility and Andrology Society and a member of the Board of Directors of the Society for the Study of Reproduction (SSR). He is the Chair of the SSR Golden Anniversary Fundraising Campaign.